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Objective: To discuss the effect and molecular mechanism of miR-146a on the
proliferation of lung cancer cells by targeting and regulating the macrophage migration
inhibitory factor (MIF) gene.
Methods: RT-PCR was employed to detect expression of miR-146a; immunohisto-
chemistry was used to detect the expression of MIF. The luciferase reporter gene tech-
nique was adopted to verify that MIF was the speciﬁc reverse target gene of miR-146a
and the liposome Lipofectamine™2000 was employed to transfer the modeled miR-146a
mimics, and miR-146a negative control (NC) in NSCLC cells to detect the expression of
MIF mRNA and protein. MTT assay was used to detect cell viability, cloning technique
to detect cell proliferation ability, AnnexinV-PI to detect cell apoptosis, UV spectro-
photometry to detect viability of cysteinyl aspartate speciﬁc proteinase 3 (Caspase 3), and
western blot to detect expression of nuclear factor-kB (NF-kB) in cells.
Results: The expression of miR-146a in NSCLC lung tissues was lower than that in the
normal lung tissues besides the lung cancer; while the expression of miR-146a in NSCLC
cells was lower than that in normal human embryonic lung tissues. It was chosen as the
subsequent cell line for its appropriate expression in A549. The expression of MIF protein
in NSCLC lung tissues was higher than that in the normal lung tissues besides the lung
cancer. The luciferase reporter gene proved that MIF was the reverse target gene of
miR-146a. The miR-146a mimics were transfected into A549 cells through the liposome.
Compared with NC group, the expression of MIF protein and mRNA was signiﬁcantly
decreased (P < 0.01), with the decrease in the cell viability (P < 0.01), the decrease in the
number of clones (P < 0.01), cell apoptosis (P < 0.01), the increase in the activity of
Caspase 3 (P < 0.01), and decrease in the phosphorylation of NF-kB p65 (P < 0.01).
Conclusions: miR-146a has low expression in NSCLC tissues and cell lines, whileMIF has
the over expression in NSCLC tissues. The increased expression of miR-146a can inhibit the
expression of MIF via the gene targeting and thus inhibit the proliferation of A549 cells and
induce the apoptosis of cancer cells,whichmaybe realized throughNF-kBsignaling pathway.1. Introduction
Lung cancer is a common malignant tumor in the respiratory
tract, and the disease caused the greatest harm to human healthin the 21st century. The lung cancer can be divided into 2 types
according to the pathological pattern, namely the small-cell lung
cancer (SCLC) and non-small cell lung cancer (NSCLC), where
the latter one occupies about 85% of the lung cancer [1,2].
NSCLC can be further divided into the squamous cell
carcinoma, adenocarcinoma and large cell lung cancer
according to the histological type. Presently, the treatment of
lung cancer is mainly surgery, accompanying comprehensive
treatments of chemotherapy, radiotherapy and targeted therapy,
but the ﬁve-year survival rate was only 15% [3,4]. It is always
the terminal stage when the lung cancer is diagnosed, as thererticle under the CC BY-NC-ND license (http://
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identify markers for early diagnosis of lung cancer will be
helpful for the treatment of lung cancer.
A great number of researches have proved that MicroRNA
(miRNAs) had the abnormal expression in many tumors and had
the close relationship with the occurrence and development of
many tumors such as the lung cancer [5–7]. Where, miR-146a is
located at LOC285628 gene of No. 5 chromosome and the
mature sequence is in the second exon. According to the pre-
vious researches, the expression of miR-146a in patients with
NSCLC was lower than that in patients with the benign lung
cancer and its expression in the lung cancers was lower than that
in normal lung cells. The low expression of miR-146a was
closely related to the high TNM staging, lymph node metastasis
and low survival rate [8–10]. It indicated that there was close
relationship between miR-146a and the occurrence and devel-
opment of NSCLC, its speciﬁc mechanism has been unknown
yet. The macrophage migration inhibitory factor (MIF) is some
kind of highly conserved protein from T-cell, which can also be
secreted by the monocytes/macrophages and anterior pituitary
cells. Many researches reported that MIF was involved in the
occurrence and development of lung cancer, especially NSCLC.
Kamimura et al [11] adopted the immunohistochemistry to study
the overexpression of MIF in the lung tissues of patients with
NSCLC, which was clearly related to the prognosis. Liu et al
[12] and Howard et al [13] also reported that the expression of
MIF in lung cancer tissues was signiﬁcantly higher than that
in the paracarcinoma tissues, which indicated that miR-146a
and MIF had the abnormal expression in NSCLC. It is
assumed that MIF might be one of reverse target proteins of
miR-146a. Therefore, on that basis, RT-PCR and immunohis-
tochemistry were employed to detect the expression of miR-
146a and MIF in NSCLC lung tissues, respectively. The lucif-
erase reporter gene was used to analyze whether MIF is the
reverse target gene of miR-146a. Furthermore, miR-146a
mimics was transfected into NSCLC cells through the lipo-
some to discuss its effect on the expression of MIF and cell
proliferation in NSCLC cells and its speciﬁc mechanism as well.
2. Materials and methods
2.1. Materials
Twenty samples of NSCLC lung tissues and 20 samples of
normal lung tissues besides the lung cancer were collected from
patients who received the surgery in Jiangxi Chest Hospital from
July 2014 to December 2014, including 12 cases with the lymph
node metastasis and 8 cases without the lymph node metastasis.
Patients were clinically staged according to 2009 UICC TNM
Staging System, including 13 cases of squamous cell carcinoma
and 7 cases of adenocarcinoma; TEM staging: 14 cases at Ⅰ–Ⅱ
stage and 6 cases at Ⅲ–Ⅳ stage. Patients were not given the
chemotherapy or radiotherapy before the operation, but they
were diagnosed pathologically.
2.2. Reagents and instruments
NSCLC cells HCC827, A549, NCI-H1650, NCI-H258 and
human embryonic lung cells WI-38 were purchased from Cell
Bank, Chinese Academy of Sciences, with the item No. of
TCHu153, TCHu150, TCHu152, TCHu151 and GNHu42respectively; the rabbit anti-NF-kB p65 and pp6 monoclonal
antibody from Epitmics; the rabbit anti-MIF monoclonal anti-
body from Cell Signaling Technology; the methyl thiazolyl
tetrazolium from Gibco; the fetal bovine serum, RPMI-1640
medium from Hyclone; Caspase 3 activity assay kit from
Nanjing KeyGen Biotech Co., Ltd.; the trizol, RT-PCR kit, wild-
type MIF 30 untranslated region (30UTR) luciferase vector
pGL3-MIF 30UTR-Wt and mutant-type MIF 30UTR luciferase
vector pGL3-MIF 30UTR-Mut from Invitrogen; miR-146a
mimics and negative control (NC) were synthesized by
Guangzhou RiboBio. The dual mini vertical electrophoresis
apparatus, mini transfer electrophoresis apparatus and Chem-
iDocTM XRS gel imaging system were purchased from Bio-
Rad; the luciferase activity assay kit from Promega.
2.3. MTT to detect the cell viability of MCF-7
NSCLC cells were seeded onto 96-well plate. When the
conﬂuency of cells reached to 50%, Lipofectamine™2000 was
transfected with miR-146a mimics and NC with the transfection
concentration of 50 nmol and 50 nmol, respectively. Fourty-
eight hours after the transfection, MTT was added for the
continuous culture of 4 h and then the supernatant were
removed. Afterwards, DMSO was added and CD value was
measured at 560 nm of analyzer of enzyme-linked immunosor-
bent assay, which was regarded as the cell viability [14].
2.4. Colony formation assay
NSCLC cells were seeded on 6-well plate. When the con-
ﬂuency of cells reached to 50%, Lipofectamine™2000 was
transfected with miR-146a mimics and NC with the transfection
concentration of 50 nmol and 50 nmol, respectively. Fourty-
eight hours after the transfection, the staining solution with
10% formaldehyde and 0.1% crystal violet was used for the
ﬁxed staining. It was placed at room temperature for 30 min.
Afterwards, the staining solution was gently ﬂung off and each
well was washed with the distilled water. The culture plate was
inverted on the absorbent paper to suck out the water. Then the
photo was taken and the analysis was performed.
2.5. AnnexinV-PI doubles staining ﬂow cytometry to
detect the cell apoptosis
NSCLC cells MCF-7 were seeded onto 6-well plate. When
the conﬂuency of cells reached to 50%, Lipofectamine™2000
was transfected with miR-146a mimics and NC with the trans-
fection concentration of 50 nmol and 50 nmol, respectively. The
operation procedure should be in accordance with the manual of
kit and it was tested on the machine.
2.6. RT-PCR
The total RNA was extracted according to the manual of
trizol kit. The primers were as follows. miR-146a forward
primer: 50-CAGTGCGTGTCGTGGAGT-30, reverse primer: 50-
GGGTGAGAACTGAATTCCA-30, length: 158 bp. MIF for-
ward primer: 50-ACTAAGAAAGACCCGAGGC-30, reverse
primer: 50-GGGGCACGTTGGTGTTTAC-30, length: 366 bp.
GAPDH forward primer: 50-AGCCACATCGCTCAGACA-30,
reverse primer: 50-TGGACTCCACGACGTACT-30, length:
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RNA into cDNA and then perform the PCR ampliﬁcation. The
collected ampliﬁcation product was used for the further testing
with agarose gel. The primers were added in 25 mL PCR system.
The reaction conditions included the denaturation at 94 C for
45 s, renaturation at 59 C for 45 s and extension at 72 C for
60 s, with 35 cycles in total.
2.7. Western blot
The RIPA lysis buffer was added in the collected cells. The
supernatant obtained from the centrifugal was the total protein.
The protein concentration was measured with BCA kit. After the
denaturation, the protein loading buffer was treated with SDS
gel electrophoresis for (1–2) h and then it was transferred with
the wet method for (30–40) min. Then the ﬁlm was incubated
into the primary antibody solution at 4 C over night. After-
wards, it was incubated into the secondary antibody solution at
the room temperature for (1–2) h. Then it was exposed in the gel
imaging system. Statistics was performed on the gray value of
each antibody band using ‘Quantity one’ software.
2.8. Immunohistochemistry to detect the expression of
MIF protein in lung tissues
Samples were ﬁxed with 10% formalin. After being
embedded and sliced into sections, they were deparafﬁnaged
with dimethylbenzene and dehydrated with anhydrous, 95% and
80% ethanol. They were washed with the running water. After
the antigen retrieval, the horse serum was employed for the
antigen blocking. After being blocked with the primary antibody
and secondary antibody, they were immersed in the hematoxylin
and hydrochloric acid alcohol. They were washed with the
running water to be antiblue and then dehydrated with the
gradient ethanol. They were clariﬁed with xylene and the neutral
balsam for mounting and results were observed under the mi-
croscope. The positive staining of MIF was light yellow and
brown yellow, which was at the cytoplasm.
2.9. Expression of luciferase reporter gene
miR-146a and MIF recombinant plasmid were transfected
into NSCLC cells, with the grouping as follows: miR-146a
mimics + Wt MIF, miR-146a mimics NC + Wt MIF, miR-
146a mimics + Mut MIF and miR-146a mimics NC + Mut
MIF. The dual luciferase assay system was employed to
detect the viability of cell luciferase. Firstly, cells were
washed with PBS. After adding PLB lysis buffer for the lysis
of 10 min, LAR solution was added and the ﬂuorescence
value was read. The stopping solution was then added and the
ﬂuorescence value was read again. The relative ﬂuorescence
value was then calculated (relative ﬂuorescence
value = ﬂuorescence value of ﬁreﬂy luciferase/ﬂuorescence
value of renilla luciferase).
2.10. Statistical analysis
All data were analyzed with SPSS 17.0 and expressed as
mean ± SD. The t test was employed and P < 0.05 was
considered to have signiﬁcant difference.3. Results
3.1. Expression of miR-146a in NSCLC lung tissues and
lung tissues beside the cancer
The expression of miR-146a in NSCLC tissues was signiﬁ-
cantly lower than that in the normal tissues beside the cancer,
with the statistical difference (P < 0.05). Expression of miR-
146a in NSCLC lung tissues and lung tissues beside the can-
cer was (0.68 ± 0.05) and (0.23 ± 0.00), respectively; and
expression of MIF in NSCLC lung tissues and lung tissues be-
side the cancer was (0.89 ± 0.02) and (5.49 ± 0.48), respectively.
3.2. Expression of miR-146a in NSCLC cell lines and
normal lung cell lines
The relative expression of miR-146a in NSCLC cell lines of
HCC827, A549, NCI-H1650 and NCI-H258 was signiﬁcantly
lower than that in the human embryonic lung cell WI-38.
Because of the appropriate expression, A549 could be chosen
as the research object. Expression of miR-146a in NSCLC cell
lines and normal lung cell lines was as follows, HCC827
(0.20 ± 0.02), A549 (0.24 ± 0.04), NCI-H1650 (0.51 ± 0.05),
and WI-38 (0.75 ± 0.02).
3.3. Expression of MIF in NSCLC lung tissues and lung
tissues beside the cancer
Compared with the normal lung tissues besides the lung
cancer, the positive expression of MIF in NSCLC lung tissues
was signiﬁcantly higher, with the statistical difference
(P < 0.01).
3.4. Expression of luciferase reporter gene
The miR-146a mimics, NC and wild-type vector pGL3-MIF
30UTR-Wt and mutant-type vector pGL3-MIF 30UTR-Mut were
transfected in A549 cells. The results indicated that the ﬂuo-
rescent intensity in the cotransfection group of miR-146a mimics
and wild-type vector pGL3-MIF 30UTR-Wt was signiﬁcantly
weaker than that in other transfection groups, with the statistical
difference (P < 0.01). For the mutant-type vector pGL3-MIF
30UTR-Mut, there was no signiﬁcant difference in the ﬂuores-
cent intensity among groups (P > 0.05). Expressions of Lucif-
erase Reporter Gene in pGL3-MIF 30UTR-Wt group were: miR-
146a NC (1.03 ± 0.10) and miR-146a mimics (0.54 ± 0.06); in
pGL3-MIF 30UTR-Mut group were: miR-146a NC (0.99 ± 0.09)
and miR-146a mimics (0.99 ± 0.11).
3.5. Effect of miR-146a mimics on expression of MIF
and mRNA in A549 cells
After transfecting miR-146a mimics and NC in A549 cells,
the expression of MIF protein and mRNA was signiﬁcantly
decreased (P < 0.01).
Effect of miR-146a NC on expression of MIF and mRNA in
A549 cells were: MIF protein (1.12 ± 0.10) and MIF mRNA
(1.40 ± 0.13); Effect of miR-146a mimics on Expression of MIF
and mRNA in A549 Cells were: MIF protein (0.35 ± 0.03) and
MIF mRNA (0.52 ± 0.05).
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After transfecting miR-146a mimics in A549 cells, the results
of MTT assay indicated that, compared with the control group,
the cell viability of transfection group was signiﬁcantly
decreased, with the statistical difference (P < 0.01) (Table 1).Table 1
Effect of miR-146a mimics on viability of A549 cells, number of clones
and apoptosis.
Type Cell viability
(%)
Number of
clones
Cell apoptosis rate (%)
Early
apoptosis
Late
apoptosis
miR-146a
NC
100.00 ± 10.10 68.34 ± 8.23 1.38 ± 0.14 13.08 ± 1.31
miR-146a
mimics
60.42 ± 6.43** 35.49 ± 3.65** 2.54 ± 0.25 38.12 ± 3.81
Compared with NC group, **P < 0.01.3.7. Effect of miR-146a mimics on colony formation of
A549 cells
After transfecting miR-146a mimics in A549 cells, the results
of cloning technique indicated that, compared with the control
group, the cloning ability of cells in the transfection group was
signiﬁcantly decreased, with the statistical difference (P < 0.01).
3.8. Effect of miR-146a mimics on apoptosis of
A549 cells
After transfecting miR-146a mimics in A549 cells, the results
of AnnexinV-PI assay indicated that, compared with the control
group, the number of cell apoptosis in the transfection group was
signiﬁcantly increased (P < 0.01).
3.9. Effect of miR-146a mimics on NF-kB signaling
pathway in A549 cells
After transfecting miR-146a mimics in A549 cells, the results
of western blot indicated that, compared with the control group,
the NF-kB p65phosphorylation in the transfection group was
signiﬁcantly decreased (P < 0.01).
Effect of miR-146a NC on NF-kB signaling pathway and
Caspase 3 activity in A549 cells were: pp65/p65
(0.43 ± 0.04) and relative activity of Caspase 3 (1.39 ± 0.13);
miR-146a mimics were: pp65/p65 (0.43 ± 0.04) and relative
activity of Caspase 3 (1.39 ± 0.13).
3.10. Effect of miR-146a mimics on Caspase 3 activity in
A549 cells
After transfecting miR-146a mimics in A549 cells, compared
with the control group, the phosphorylation of Caspase 3 in the
transfection group was signiﬁcantly increased (P < 0.01).
4. Discussion
The development and progression of NSCLC tumor is a
process that involves multiple factors and steps, being presented
as the activation of oncogenes and inactivation of tumorsuppressor genes ﬁnally. A great number of researches have
proved that miRNAs serve as the cancer suppressor or cancer
promoter in different tumors and play a critical role in the pro-
liferation and apoptosis of tumor cells, signal transduction and
the regulation of tumor pathogenesis [5–7]. As some kind of
tumor suppressing gene, the expression of miR-146a was
down-regulated in many types of cancer cells [15–19]. Wang et al
[20] reported that the expression of miR-146a in the serum of
NSCLC was higher than that in cells of normal persons. Jia et al
[9] found that the expression of miR-146a in patients with
NSCLC was lower than that in the benign lung cancer tissues.
According to Wu et al [10], the low expression of miR-146a in
NSCLC was closely related to the high TNM staging, lymph
node metastasis and low survival rate and the high expression of
miR-146a in NSCLC was related to the high overall response
rate and high survival rate. Chen et al [14] proved that the low
expression of miR-146a in NSCLC was closely related ot the
high TNM staging and distant metastasis. Cornett et al [8]
reported that the expression of miR-146a in the lung cancer
cells was signiﬁcantly lower than that in the normal lung cells,
which fully indicated that there was the close relationship be-
tween miR-146a and the occurrence and development of
NSCLC. The results of this study were in accordance with above
ﬁndings. The expression of miR-146a in NSCLC lung tissues
was lower than that in the lung tissues beside the cancer and its
expression in NSCLC cell lines of HCC827, A549, NCI-H1650
and NCI-H258 was also lower than that in the human embryonic
lung cell WI-38. Because of the appropriate expression of miR-
146a in A549, it was chosen as the cell line of subsequent
experiment.
Furthermore, the previous researches have proved that
miRNAs could regulate the biological behavior of tumor cells by
targeting some molecules [21–23]. The analysis of luciferase
reporter gene proved that MIF was the reverse target gene of
miR-146a. MIF is some kind of cytokine from T lymphocytes,
which can inhibit the migration of macrophages and cause the
aggregation and inﬁltration of macrophages in the delayed type
hypersensitivity to be involved in the inﬂammatory response.
Besides, MIF is regulated by the hypothalamus and pituitary
system, which plays an important role in the apoptosis and
proliferation of tumor cells and the development of malignant
tumors. The expression of MIF was relatively high in the cancer
tissues of melanoma, NSCLC, prostate cancer and colorectal
cancer [24]. In this study, the results of immunohistochemistry
also proved that the expression of MIF protein and mRNA in
NSCLC was higher than that in the tissues beside the cancer.
In addition, according to the immunohistochemistry by
Kamimura et al [11], MIF was overexpressed in the lung
tissues of patients with NSCLC and it was related to the
prognosis. Howard et al [13] also found that the expression of
MIF in the lung cancer tissues was signiﬁcantly higher than
that in the tissues beside the cancer. White et al [25] reported
that the high expression of MIF in NSCLC lung tissues was
positively related to the high expression of VEGF in the blood
and the microvessel density of tumor tissues. It fully indicated
that MIF was overexpressed in NSCLC and it was closely
related to the occurrence and development of NSCLC.
Meanwhile, by up-regulating the expression of miR-146a, it
could signiﬁcantly inhibit the expression of MIF protein and
mRNA in A549 cells, which indicated that MIF was the reverse
target molecule of miR-146a protein. Accordingly, on that basis,
it would further discuss the mechanism of miR-146a that
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geting MIF molecule.
The inﬁnite proliferation of tumor can result in the
continuous division and proliferation of tumor cells, which
makes the anabolism of protein higher than the catabolism in
the tumor cells. It can even grab the products of protein
metabolism in normal cells to make the organism in the con-
dition of cachexia and thus aggravate the illness. Thus to
induce the apoptosis of tumor cells would be an effective
measure to inhibit the inﬁnite proliferation of tumor. Chen et al
[14] transfected miR-146a mimics in NSCLC cell lines of
H358, H1650, H1975, HCC827 and H292 and found that it
could signiﬁcantly inhibit the cell proliferation and induce the
cell apoptosis. Mawhinney et al [26] reported that the growth of
primary tumor in the mouse with Lewis lung cancer that
knocked out MIF or lacked the MIF activity was slower than
that in the wild-type mouse. Thus in this study, by trans-
fecting miR-146a mimics in A549 cells, it found that the
viability of tumor cells and cloning ability were decreased and
the apoptosis rate was increased, which indicated that the up-
regulated expression of miR-146a could target inhibiting the
expression of MIF and thus induce the apoptosis of A549 cells.
The proliferation and apoptosis of tumor cells were regulated
by the apoptosis signaling pathway. NF-kB signaling pathway
is one of common signaling pathways. In the condition without
the stimulation or in normal physiological conditions, it can be
bound with IkB. But in the condition with the stimulation or in
pathological conditions, IkB will be degraded and phosphor-
ylated to release NF-kB p65 and transfer it from the cytoplasm
to the nucleus, in order to regulate the expression of apoptosis-
related genes such as Caspase 3. According to previous re-
searches, the activity of NF-kB p65 was signiﬁcantly increased
in NSCLC and the interference against its activity to the
certain extent could inhibit the proliferation of tumor cells [27–
30]. In addition, the promoter region of miR-146a has the
binding site of NF-kB. miR-146a could negatively regulate
NF-kB signaling pathway and thus affect the process of tumor
formation [31,32]. Paik et al [31] found that in the cell lines of
NK/T cell lymphoma, miR-146a could interfere with
TRAF6/NF-kB pathway to inhibit the cell proliferation, pro-
mote the cell apoptosis and increase the sensitivity of
chemotherapy. The knockout of miR-146a gene in C57BL/6
mice could cause the malignant tumor of myelocytes, with the
high expression of NF-kB p65 in the spleen and nucleus of
bone marrow of mice and the increase in the transcription of
reverse genes [32]. It fully indicated that miR-146a could make
NF-kB p65 lose the activity and then signiﬁcantly inhibit the
proliferation of tumor cells and induce the apoptosis of tumor
cells. Meanwhile, it also found that during the stroke of mice,
the over expression of MIF would also reduce the activity of
Caspase 3 and inhibit the apoptosis of neurons, which was
realized through NF-kB signaling pathway [33]. siRNA MIF
could signiﬁcantly induce the apoptosis of H460 tumor cells
and increase the activity of Caspase 3 and Caspase 4 [34]. It
indicated that the down-regulated expression of MIF could
inhibit the activity of NF-kB to increase the activity of Cas-
pase 3 and thus induce the apoptosis of tumor cells. It could be
assumed that the up-regulated expression of miR-146a could
target inhibiting the expression of MIF in A549 cells to induce
the apoptosis of A549 cells, which could be realized by
inhibiting NF-kB signaling pathway. The results of this study
also proved such assumption. To be speciﬁc, after the up-regulated expression of miR-146a, the apoptosis of
A549 cells was increased, with the decreased phosphorylation
of NF-kB p65 and the increased activity of Caspase 3.
In conclusion, miR-146a had the low expression in NSCLC
lung tissues and cell lines and MIF had the overexpression in
NSCLC lung tissues. The up-regulated expression of miR-146a
could target inhibiting the expression of MIF to inhibit the
proliferation and induce the apoptosis of A549 cells, which
could be realized by inhibiting NF-kB signaling pathway. In
addition, miR-146a/b could negatively regulate the activity of
NF-kB p65 in MDA-MB-231 cells of breast cancer to inhibit the
metastasis of tumor cells [35]. Therefore, the further experiment
can discuss the effect of miR-146a on the biological behavior
such as the invasion and metastasis of NSCLC cells through
such signaling pathway.
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